You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ombitasvir

Showing 26 - 50 of 110
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Chronic

Completed
Has Results
  • Chronic Hepatitis C
    • (no location specified)
    Sep 16, 2019

    Naïve Hepatitis C Virus Genotype 1 Suffering From Fatigue and

    Completed
    Has Results
    • Chronic Hepatitis C Virus (HCV)
      • St. Gallen, Sankt Gallen, Switzerland
      • +4 more
      Sep 30, 2019

      Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin and

      Completed
      Has Results
      • Chronic Hepatitis C
      • Be'er Sheva, HaDarom, Israel
      • +17 more
      Sep 18, 2019

      Resistance to AbbVie's 2 Direct-acting Antiviral Agent Therapy

      Completed
      • Hepatitis C Virus
        • Nagoya-shi, Aichi, Japan
        • +52 more
        Dec 6, 2021

        Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Chronic

        Completed
        Has Results
        • Chronic Hepatitis C
          • (no location specified)
          May 23, 2019

          Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Chronic

          Completed
          Has Results
          • Chronic Hepatitis C
            • Bogotá, Colombia
            • +5 more
            Aug 12, 2019

            Hepatitis C Trial in Ottawa (ABT450r-ABT267-ABT333 +/- Ribavirin)

            Completed
            • Hepatitis C
            • ABT450r-ABT267-ABT333 +/- Ribavirin
            • Ottawa, Ontario, Canada
              The Ottawa Hospital, General Campus
            Aug 9, 2019

            ABT-450/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Chronic

            Completed
            Has Results
            • Chronic Hepatitis C
            • (no location specified)
            May 1, 2019

            Chronic Hepatitis C Trial in United States (SOF/LDV (sofosbuvir/ledipasvir), PrOD (ombitasvir/paritaprevir/ritonavir with

            Completed
            Has Results
            • Chronic Hepatitis C
            • SOF/LDV (sofosbuvir/ledipasvir)
            • +3 more
            • Little Rock, Arkansas
            • +37 more
            Dec 1, 2021

            Paritaprevir/Ritonavir - Ombitasvir, ± Dasabuvir, ± Ribavirin in

            Completed
            Has Results
            • Chronic Hepatitis C, Genotype 1 or 4
            • (no location specified)
            Feb 6, 2019

            Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Chronic

            Completed
            Has Results
            • Chronic Hepatitis C
              • (no location specified)
              Feb 28, 2019

              Hepatitis C Virus Trial (Paritaprevir, Ritonavir, Dasabuvir)

              Unknown status
              • Hepatitis C Virus
              • (no location specified)
              Oct 4, 2019

              Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Chronic

              Completed
              Has Results
              • Chronic Hepatitis C
              • (no location specified)
              Mar 26, 2019

              Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Chronic

              Completed
              Has Results
              • Chronic Hepatitis C
              • (no location specified)
              Oct 22, 2018

              Hepatitis C, Chronic Trial in Sydney ("3D" regimen, "3D" regimen with ribavirin)

              Completed
              • Hepatitis C, Chronic
              • "3D" regimen
              • "3D" regimen with ribavirin
              • Sydney, New South Wales, Australia
                The Kirby Institute, University of New South Wales Australia
              Jun 11, 2019

              HCV Coinfection Trial in Assiut (Sofosbuvir, Simeprevir, Daclatasvir)

              Completed
              • HCV Coinfection
              • Assiut, Egypt
                Assiut University Hopsital
              Mar 17, 2019

              HCV Coinfection Trial in Afula (VEKIRAX, EXVIERA)

              Completed
              • HCV Coinfection
              • Afula, Israel
                Haemek medical center
              Aug 8, 2019

              Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin and

              Completed
              Has Results
              • Chronic Hepatitis C
                • Dordrecht, Zuid-Holland, Netherlands
                • +8 more
                May 15, 2019

                Paritaprevir/Ritonavir, Ombitasvir, + Dasabuvir, ± Ribavirin in

                Completed
                Has Results
                • Chronic Hepatitis C
                  • (no location specified)
                  Aug 2, 2018

                  Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Chronic

                  Completed
                  Has Results
                  • Chronic Hepatitis C
                    • (no location specified)
                    Jun 11, 2018

                    HCV Patients Receiving SOF-based or SOF-free DAAs

                    Completed
                    • Hepatitis C
                    • +2 more
                    • Sofosbuvir / Velpatasvir Oral Tablet
                    • +5 more
                    • Douliu, Taiwan
                    • +1 more
                    Aug 6, 2019

                    Hepatitis Viruses Trial in Taiwan (PTV/r/OBV/DSV)

                    Completed
                    Has Results
                    • Hepatitis Viruses
                    • Chiayi City, Taiwan
                    • +7 more
                    May 10, 2019

                    Paritaprevir/Ritonavir - Ombitasvir, + Dasabuvir Without

                    Completed
                    Has Results
                    • Chronic Hepatitis C
                      • Chelyabinsk, Russian Federation
                      • +6 more
                      Nov 20, 2018

                      Viekira/Exviera for Korean Hepatitis C Patients According to

                      Completed
                      • Hepatitis C Virus (HCV)
                        • Busan, Busan Gwang Yeogsi, Korea, Republic of
                        • +58 more
                        Oct 6, 2020

                        Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Chronic

                        Completed
                        Has Results
                        • Chronic Hepatitis C
                        • Genotype 1
                          • (no location specified)
                          Oct 18, 2018